Idexx Laboratories | IDXX - Net Income


Idexx Laboratories reported $278.45M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
Align Technology USD 112.77M 22.99M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Dentsply International USD -10M 136M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fujifilm JPY 84.24B 11.58B Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Henry Schein USD 107M 6M Mar/2026
Idexx Laboratories USD 278.45M 30.26M Mar/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Neogen USD -17M 1.08M Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Steris USD 220.3M 27.4M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zoetis USD 601M 2M Mar/2026